Centre de neurosciences psychiatriques - CNP

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


1492 publications

 
Task-Specific Temporal Prediction Mechanisms Revealed by Motor and Electroencephalographic Indicators
Arrouet Alana, Carneiro Eduardo, Marquet Pierre, Giersch Anne Neuroimage. Peer-reviewed.
 
Cellular Dynamics Revealed by Digital Holographic Microscopy
Marquet Pierre, Depeursinge Christain, Jourdain PAscal dans The New Encyclopedia of Neuroscience, L. Squire,, (Elsevier BV)..
 
Mathematical properties of pump-leak-cotransport models
Ouellet Vincent, Price Julia, Doyon Nicolas, Godin Antoine, Marquet Pierre Journal of Mathematical Biology. Peer-reviewed.
 
Therapeutic Drug Monitoring of Olanzapine: Effects of Clinical Factors on Plasma Concentrations in Psychiatric Patients.
Ansermot N., Vathanarasa H., Ranjbar S., Gholam M., Crettol S., Vandenberghe F., Gamma F., Plessen K.J., von Gunten A., Conus P. et al. Therapeutic drug monitoring. Peer-reviewed.
 
Individualized pretest risk estimates to guide treatment decisions in patients with clinical high risk for psychotic disorders.
Sprüngli-Toffel E., Studerus E., Curtis L., Conchon C., Alameda L., Bailey B., Caron C., Haase C., Gros J., Herbrecht E. et al. Spanish journal of psychiatry and mental health. Peer-reviewed.
 
Psychotropic-induced weight gain and telomere length: results from a one-year longitudinal study and a large population-based cohort.
Piras M., Lin J., Sadler M.C., Ranjbar S., Grosu C., Laaboub N., Preisig M., Gamma F., Plessen K.J., von Gunten A. et al., 2024/11/15. Translational psychiatry, 14 (1) p. 471. Peer-reviewed.
A population pharmacokinetic model for sertraline in women during the perinatal period-A contribution from the ConcePTION project.
Monfort A., Cardoso E., Eap C.B., Ansermot N., Crettol S., Fischer Fumeaux C.J., Graz M.B., Harari M.M., Weisskopf E., Gandia P. et al., 2024/11. British journal of clinical pharmacology, 90 (11) pp. 2849-2860. Peer-reviewed.
Neurocognition and NMDAR co-agonists pathways in individuals with treatment resistant first-episode psychosis: a 3-year follow-up longitudinal study.
Camporesi S., Xin L., Golay P., Eap C.B., Cleusix M., Cuenod M., Fournier M., Hashimoto K., Jenni R., Ramain J. et al., 2024/11. Molecular psychiatry, 29 (11) pp. 3669-3679. Peer-reviewed.
 
Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics.
Hart X.M., Gründer G., Ansermot N., Conca A., Corruble E., Crettol S., Cumming P., Frajerman A., Hefner G., Howes O. et al., 2024/11. The world journal of biological psychiatry, 25 (9) pp. 451-536. Peer-reviewed.
 
Visualizing the fine structure and dynamics of living cells with time-lapse polychromatic digital holographic microscopy
Haouat Mohamed, Larivière-Loiselle Céline, Crochetière Marie-Ève, Chaniot Johan, Moreaud Maxime, Bélanger Erik, Marquet Pierre, 2024/10/03. Journal of the Optical Society of America A. Peer-reviewed.
 
About statistical significance, and the lack thereof.
Magara F., Boury-Jamot B., 2024/10. Laboratory animals, 58 (5) pp. 448-452. Peer-reviewed.
 
Quantitative estimation of optical properties in bilayer media within the subdiffusive regime using a tilted fiber-optic probe in diffuse reflectance spectroscopy, part 1: a theoretical framework for designing probe geometry.
De Tillieux P., Baillot M., Marquet P., 2024/10. Journal of biomedical optics, 29 (10) p. 105001. Peer-reviewed.
 
Quantitative estimation of optical properties in bilayer media within the subdiffusive regime using tilted fiber-optic probe diffuse reflectance spectroscopy, part 2: probe design, realization, and experimental validation.
De Tillieux P., Baillot M., Marquet P., 2024/10. Journal of biomedical optics, 29 (10) p. 105002. Peer-reviewed.
Winter birth: A factor of poor functional outcome in a Swiss early psychosis cohort.
Restellini R., Golay P., Jenni R., Baumann P.S., Alameda L., Allgäuer L., Steullet P., Abrahamyan Empson L., Mebdouhi N., Do K.Q. et al., 2024/09/27. Schizophrenia research, 274 pp. 206-211. Peer-reviewed.
 
Pharmacokinetics and Pharmacodynamics of Inhaled Nicotine Salt and Free-Base Using an E-cigarette: A Randomized Crossover Study.
Christen S.E., Hermann L., Bekka E., Vonwyl C., Hammann F., van der Velpen V., Eap C.B., Benowitz N.L., Haschke M., Liakoni E., 2024/09/23. Nicotine & tobacco research, 26 (10) pp. 1313-1321. Peer-reviewed.
 
Long-term changes in adiposity markers during and after antidepressant therapy in a community cohort.
Mwinyi J., Strippoli M.F., Kanders S.H., Schiöth H.B., Eap C.B., Lasserre A.M., Marques-Vidal P., Vandeleur C.L., Preisig M., 2024/08/13. Translational psychiatry, 14 (1) p. 330. Peer-reviewed.
Aripiprazole dose associations with metabolic adverse effect: Results from a longitudinal study.
Piras M., Popovic I., Ranjbar S., Grosu C., Laaboub N., Sentissi O., Lakhal M.H., Gamma F., Plessen K.J., von Gunten A. et al., 2024/08. Schizophrenia research, 270 pp. 403-409. Peer-reviewed.
 
Self-reported caffeine consumption miss-matched consumption measured by plasma levels of caffeine and its metabolites: results from two population-based studies.
Laaboub N., Ranjbar S., Strippoli M.F., Marques-Vidal P., Estoppey-Younes S., Ponte B., Pruijm M., Vogt B., Ansermot N., Crettol S. et al., 2024/08. European journal of nutrition, 63 (5) pp. 1555-1564. Peer-reviewed.
 
Fear learning induces synaptic potentiation between engram neurons in the rat lateral amygdala.
Abatis M., Perin R., Niu R., van den Burg E., Hegoburu C., Kim R., Okamura M., Bito H., Markram H., Stoop R., 2024/07. Nature neuroscience, 27 (7) pp. 1309-1317. Peer-reviewed.
 
Updates from the third residential course on child and adolescent psychiatry endorsed by the European Society for Child and Adolescent mental health-ESCAP.
Riccioni A., Siracusano M., Davico C., Klauser P., Morcillo C., Ougrin D., Vitiello B., Plessen K.J., Armando M., Mazzone L. et al., 2024/07. European child & adolescent psychiatry, 33 (7) pp. 2437-2439. Peer-reviewed.
 
Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definition.
Schoretsanitis G., Anıl Yağcıoğlu A.E., Ruan C.J., Eap C.B., Molden E., Baptista T., Clark S.R., Fernandez-Egea E., Kim S.H., Lane H.Y. et al., 2024/06. Schizophrenia research, 268 pp. 302-307. Peer-reviewed.
 
Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients: A literature review and a case series of 17 patients from 3 studies.
Ruan C.J., Olmos I., Ricciardi C., Schoretsanitis G., Vincent P.D., Anıl Yağcıoğlu A.E., Eap C.B., Baptista T., Clark S.R., Fernandez-Egea E. et al., 2024/06. Schizophrenia research, 268 pp. 293-301. Peer-reviewed.
Matrix metalloproteinase 9 (MMP-9) activity, hippocampal extracellular free water, and cognitive deficits are associated with each other in early phase psychosis.
Seitz-Holland J., Alemán-Gómez Y., Cho KIK, Pasternak O., Cleusix M., Jenni R., Baumann P.S., Klauser P., Conus P., Hagmann P. et al., 2024/06. Neuropsychopharmacology, 49 (7) pp. 1140-1150. Peer-reviewed.
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis.
Wannan CMJ, Nelson B., Addington J., Allott K., Anticevic A., Arango C., Baker J.T., Bearden C.E., Billah T., Bouix S. et al., 2024/04/30. Schizophrenia bulletin, 50 (3) pp. 496-512. Peer-reviewed.
Dissecting unique and common variance across body and brain health indicators using age prediction.
Beck D., de Lange A.G., Gurholt T.P., Voldsbekk I., Maximov I.I., Subramaniapillai S., Schindler L., Hindley G., Leonardsen E.H., Rahman Z. et al., 2024/04/15. Human brain mapping, 45 (6) pp. e26685. Peer-reviewed.
 
Antihistaminiques : une histoire sans fin [Antihistamines : An ongoing narrative]
Vandenberghe-Dürr S., Harr T., Vandenberghe F., 2024/04/03. Revue medicale suisse, 20 (868) pp. 711-719. Peer-reviewed.
 
Behind the Curtain: Therapeutic Drug Monitoring of Psychotropic Drugs from a Laboratory Analytical Perspective.
Scherf-Clavel M., Baumann P., Hart X.M., Schneider H., Schoretsanitis G., Steimer W., Zernig G., Zurek G., 2024/04/01. Therapeutic drug monitoring, 46 (2) pp. 143-154. Peer-reviewed.
 
Associations of Valproate Doses With Weight Gain in Adult Psychiatric Patients: A 1-Year Prospective Cohort Study.
Grosu C., Hatoum W., Piras M., Laaboub N., Ranjbar S., Gamma F., Plessen K.J., von Gunten A., Preisig M., Conus P. et al., 2024/03/27. The Journal of clinical psychiatry, 85 (2). Peer-reviewed.
Associations between antipsychotics-induced weight gain and brain networks of impulsivity.
Grosu C., Klauser P., Dwir D., Khadimallah I., Alemán-Gómez Y., Laaboub N., Piras M., Fournier M., Preisig M., Conus P. et al., 2024/03/26. Translational psychiatry, 14 (1) p. 162. Peer-reviewed.
 
Social buffering in rats reduces fear by oxytocin triggering sustained changes in central amygdala neuronal activity.
Hegoburu C., Tang Y., Niu R., Ghosh S., Triana Del Rio R., de Araujo Salgado I., Abatis M., Alexandre Mota Caseiro D., van den Burg E.H., Grundschober C. et al., 2024/03/07. Nature communications, 15 (1) p. 2081. Peer-reviewed.
DNA methylation may partly explain psychotropic drug-induced metabolic side effects: results from a prospective 1-month observational study.
Dubath C., Porcu E., Delacrétaz A., Grosu C., Laaboub N., Piras M., von Gunten A., Conus P., Plessen K.J., Kutalik Z. et al., 2024/02/28. Clinical epigenetics, 16 (1) p. 36. Peer-reviewed.
Inactivation of hypocretin receptor-2 signaling in dopaminergic neurons induces hyperarousal and enhanced cognition but impaired inhibitory control.
Bandarabadi M., Li S., Aeschlimann L., Colombo G., Tzanoulinou S., Tafti M., Becchetti A., Boutrel B., Vassalli A., 2024/02. Molecular psychiatry, 29 (2) pp. 327-341. Peer-reviewed.
 
The 2023 ESCAP Research Academy workshop: ADHD and emotional dysregulation.
Klauser P., Cortese S., Hagstrøm J., Stringaris A., Hebebrand J., Hoekstra P.J., Schlaegel K., Revet A., 2024/02. European child & adolescent psychiatry, 33 (2) pp. 633-635. Peer-reviewed.
Sex-specific interactions between stress axis and redox balance are associated with internalizing symptoms and brain white matter microstructure in adolescents.
Schilliger Z., Alemán-Gómez Y., Magnus Smith M., Celen Z., Meuleman B., Binz P.A., Steullet P., Do K.Q., Conus P., Merglen A. et al., 2024/01/17. Translational psychiatry, 14 (1) p. 30. Peer-reviewed.
 
Characterizing microstructures with representative tortuosities
Chaniot Johan, Moreaud Maxime, Sorbier Loïc, Marquet Pierre, Becker Jean-Marie, Fournel Thierry, 2024. Science and Technology for Energy Transition, 79 p. 31. Peer-reviewed.
Circulating Biomarkers for Alzheimer's Disease: Unlocking the Diagnostic Potential in Low- and Middle-Income Countries, Focusing on Africa.
Nwamekang Belinga L., Espourteille J., Wepnyu Njamnshi Y., Zafack Zeukang A., Rouaud O., Kongnyu Njamnshi A., Allali G., Richetin K., 2024. Neuro-degenerative diseases, 24 (1) pp. 26-40. Peer-reviewed.
How socioprofessional factors effect serious suicide attemps: a case-control study
Saillant S., Paz J., Golay P., Ostertag L., Costanza A., Van der Vaeren B., Dorogi Y., Michaud L., Guseva-Canu I., 2024. Acta Biomedica Atenei Parmensis, 95 (4) pp. e2024055. Peer-reviewed.
Metabolic disturbances are risk factors for readmission to psychiatric hospitals in non-smokers but not in smokers: results from a Swiss psychiatric cohort and in first-episode psychosis patients.
Laaboub N., Locatelli I., Grosu C., Piras M., Ngoc T.H., Ranjbar S., Preisig M., Elowe J., von Gunten A., Conus P. et al., 2024. Frontiers in psychiatry, 15 p. 1256416. Peer-reviewed.
Nöropsikofarmakolojide Terapötik İla ç İzlemi İ çin Ortak Görü ş Kılavuzu: 2017 G üncellemesi
Hiemke C., Bergemann N., Clement H. W., Conca A., Deckert J., Domschke K., Eckermann G., Egberts K., Gerlach M., Greiner C. et al., 2024. 81, ğlığı Derneği, Bayt Publications.
Prediction of antipsychotics efficacy based on a polygenic risk score: a real-world cohort study.
De Pieri M., Ferrari M., Pistis G., Gamma F., Marino F., Von Gunten A., Conus P., Cosentino M., Eap C.B., 2024. Frontiers in pharmacology, 15 p. 1274442. Peer-reviewed.
TDM, Arzneimitteltherapie-Sicherheit und Pharmakovigilanz
Baumann Pierre, Schoretsanitis Georgios, 2024. Info Neurologie & Psychiatrie, 22 (1) pp. 26-27.
Oxidative stress induced by sustained supraphysiological intrastriatal GDNF delivery is prevented by dose regulation.
Azevedo M.D., Prince N., Humbert-Claude M., Mesa-Infante V., Jeanneret C., Golzne V., De Matos K., Jamot B.B., Magara F., Gonzalez-Hernandez T. et al., 2023/12/14. Molecular therapy. Methods & clinical development, 31 p. 101106. Peer-reviewed.
Comprehensive proteomic analysis of JC polyomavirus-infected human astrocytes and their extracellular vesicles.
Oberholster L., Mathias A., Perriot S., Blaser E., Canales M., Jones S., Culebras L., Gimenez M., Kaynor G.C., Sapozhnik A. et al., 2023/12/12. Microbiology spectrum, 11 (6) pp. e0275123. Peer-reviewed.
Exploring the Interplay of Age and Pedagogy in the Maturation of Error‐Monitoring
Denervaud Solange, Tovar David A., Knebel Jean-François, Mullier Emeline, Alemán-Gómez Yasser, Hagmann Patric, Murray Micah M., 2023/12. Mind, Brain, and Education. Peer-reviewed.
Risk factors for mood disorders among offspring of parents with bipolar disorder: Findings from a discordant-sibling study.
Giacomo F.D., Strippoli M.F., Castelao E., Amoussou J.R., Gholam M., Ranjbar S., Glaus J., Marquet P., Preisig M., Plessen K.J. et al., 2023/12. Psychiatry research, 330 p. 115615. Peer-reviewed.
 
The Swiss Brain Health Plan 2023–2033
Bassetti Claudio L. A., Heldner Mirjam R., Adorjan Kristina, Albanese Emiliano, Allali Gilles, Arnold Marcel, Bègue Indrit, Bochud Murielle, Chan Andrew, do Cuénod Kim Q. et al., 2023/11/13. Clinical and Translational Neuroscience, 7 (4) p. 38.
Chronic oxytocin-driven alternative splicing of Crfr2α induces anxiety.
Winter J., Meyer M., Berger I., Royer M., Bianchi M., Kuffner K., Peters S., Stang S., Langgartner D., Hartmann F. et al., 2023/11. Molecular psychiatry, 28 (11) pp. 4742-4755. Peer-reviewed.
Switching antipsychotics to partial dopamine D2-agonists in individuals affected by schizophrenia: a narrative review.
Baumann P., Bauknecht P., Kuzin M., Schoretsanitis G., 2023/11. International journal of psychiatry in clinical practice, 27 (4) pp. 367-384. Peer-reviewed.
Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis.
Kuzo N., Haen E., Ho D.M., Takeuchi H., Piras M., Eap C.B., de Filippis R., Homan P., Kane J.M., Roy M.A. et al., 2023/10. European archives of psychiatry and clinical neuroscience, 273 (7) pp. 1567-1578. Peer-reviewed.
Research training in child and adolescent psychiatry: lack of motivation or a structural problem?
Kindler J., Kaess M., Eliez S., Cosentino M., Liebrand M., Klauser P., 2023/10. European child & adolescent psychiatry, 32 (10) pp. 1817-1820. Peer-reviewed.
 
Use of pharmacological treatment for posttraumatic stress disorder: Analysis of a psychiatric population in Switzerland and comparison with international guidelines.
Montavon F., Vandenberghe F., Eap C.B., 2023/10. L'Encephale, 49 (5) pp. 446-452. Peer-reviewed.
 
Cell biomarker and drug screening for bipolar disorder
Marquet Pierre, Jourdain Pascal, 2023/09/28., Demande de brevet provisoire no 63/541,217 déposée auprès du Bureau des brevets américain.
 
Prescription d’antipsychotiques chez les adultes : à quoi faut-il être attentif ? [Antipsychotic prescribing in adults : what to watch out for ?]
Grandjean C., Vandenberghe F., Dubath C., Sibailly G., Ansermot N., Crettol Wavre S., Eap C.B., 2023/09/20. Revue medicale suisse, 19 (842) pp. 1707-1712. Peer-reviewed.
ASIC1a affects hypothalamic signaling and regulates the daily rhythm of body temperature in mice.
Peng Z., Ziros P.G., Martini T., Liao X.H., Stoop R., Refetoff S., Albrecht U., Sykiotis G.P., Kellenberger S., 2023/08/17. Communications biology, 6 (1) p. 857. Peer-reviewed.
Developmental changes in cerebral NAD and neuroenergetics of an antioxidant compromised mouse model of schizophrenia.
Skupienski R., Steullet P., Do K.Q., Xin L., 2023/08/05. Translational psychiatry, 13 (1) p. 275. Peer-reviewed.
Towards a youth mental health paradigm: a perspective and roadmap.
Uhlhaas P.J., Davey C.G., Mehta U.M., Shah J., Torous J., Allen N.B., Avenevoli S., Bella-Awusah T., Chanen A., Chen EYH et al., 2023/08. Molecular psychiatry, 28 (8) pp. 3171-3181. Peer-reviewed.
 
Automated Dual-Mode Cell Monitoring To Simultaneously Explore Calcium Dynamics and Contraction-Relaxation Kinetics within Drug-Treated Stem Cell-Derived Cardiomyocytes.
Jaferzadeh K., Rappaz B., Kim Y., Kim B.K., Moon I., Marquet P., Turcatti G., 2023/07/28. ACS sensors, 8 (7) pp. 2533-2542. Peer-reviewed.
GSK-3β orchestrates the inhibitory innervation of adult-born dentate granule cells in vivo.
Moreno-Jiménez E.P., Flor-García M., Hernández-Vivanco A., Terreros-Roncal J., Rodríguez-Moreno C.B., Toni N., Méndez P., Llorens-Martín M., 2023/07/23. Cellular and molecular life sciences, 80 (8) p. 225. Peer-reviewed.
Is Clozapine-induced Weight Gain Dose-dependent? Results From a Prospective Cohort Study.
Piras M., Chahma J., Ranjbar S., Laaboub N., Grosu C., Plessen K.J., von Gunten A., Conus P., Eap C.B., 2023/07/04. Schizophrenia bulletin, 49 (4) pp. 944-952. Peer-reviewed.
 
A genetically encoded sensor measures temporal oxytocin release from different neuronal compartments.
Qian T., Wang H., Wang P., Geng L., Mei L., Osakada T., Wang L., Tang Y., Kania A., Grinevich V. et al., 2023/07. Nature biotechnology, 41 (7) pp. 944-957. Peer-reviewed.
 
Author Correction: A consensus protocol for functional connectivity analysis in the rat brain.
Grandjean J., Desrosiers-Gregoire G., Anckaerts C., Angeles-Valdez D., Ayad F., Barrière D.A., Blockx I., Bortel A., Broadwater M., Cardoso B.M. et al., 2023/06. Nature neuroscience, 26 (6) pp. 1127-1128. Peer-reviewed.
Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysis.
Sjaarda J., Delacrétaz A., Dubath C., Laaboub N., Piras M., Grosu C., Vandenberghe F., Crettol S., Ansermot N., Gamma F. et al., 2023/06. Molecular psychiatry, 28 (6) pp. 2320-2327. Peer-reviewed.
Objective polysomnography-based sleep features and major depressive disorder subtypes in the general population.
Solelhac G., Berger M., Strippoli M.F., Marchi N.A., Stephan A., Petit J.M., Bayon V., Imler T., Haba-Rubio J., Raffray T. et al., 2023/06. Psychiatry research, 324 p. 115213. Peer-reviewed.
Redox and Immune Signaling in Schizophrenia: New Therapeutic Potential.
Dwir D., Khadimallah I., Xin L., Rahman M., Du F., Öngür D., Do K.Q., 2023/05/31. The international journal of neuropsychopharmacology, 26 (5) pp. 309-321. Peer-reviewed.
Characterization of early psychosis patients carrying a genetic vulnerability to redox dysregulation: a computational analysis of mechanism-based gene expression profile in fibroblasts.
Giangreco B., Dwir D., Klauser P., Jenni R., Golay P., Cleusix M., Baumann P.S., Cuénod M., Conus P., Toni N. et al., 2023/05. Molecular psychiatry, 28 (5) pp. 1983-1994. Peer-reviewed.
 
Exploring the mediation of DNA methylation across the epigenome between childhood adversity and First Episode of Psychosis-findings from the EU-GEI study.
Alameda L., Liu Z., Sham P.C., Aas M., Trotta G., Rodriguez V., Di Forti M., Stilo S.A., Kandaswamy R., Arango C. et al., 2023/05. Molecular psychiatry, 28 (5) pp. 2095-2106. Peer-reviewed.
The Influence of a Roux-en-Y Gastric Bypass on Plasma Concentrations of Antidepressants.
Garin P., Favre L., Vionnet N., Frantz J., Eap C.B., Vandenberghe F., 2023/05. Obesity surgery, 33 (5) pp. 1422-1430. Peer-reviewed.
Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis.
Merritt K., McCutcheon R.A., Aleman A., Ashley S., Beck K., Block W., Bloemen OJN, Borgan F., Boules C., Bustillo J.R. et al., 2023/05. Molecular psychiatry, 28 (5) pp. 2039-2048. Peer-reviewed.
 
A consensus protocol for functional connectivity analysis in the rat brain.
Grandjean J., Desrosiers-Gregoire G., Anckaerts C., Angeles-Valdez D., Ayad F., Barrière D.A., Blockx I., Bortel A., Broadwater M., Cardoso B.M. et al., 2023/04. Nature neuroscience, 26 (4) pp. 673-681. Peer-reviewed.
Case report: Treatment-resistant depression, multiple trauma exposure and suicidality in an adolescent female with previously undiagnosed Autism Spectrum Disorder.
Secci I., Petigas L., Cuenod A., Klauser P., Kapp C., Novatti A., Armando M., 2023/04. Frontiers in psychiatry, 14 p. 1151293. Peer-reviewed.
Citalopram in vitro metabolism in a Beagle dog: A role for CYP2D15 in the production of toxic didesmethylcitalopram?
Rochat B., Paus E., Maitre C., Baumann P., 2023/04. Veterinarni medicina, 68 (4) pp. 135-144. Peer-reviewed.
Learning with fun: the 2nd residential course on child and adolescent psychiatry in Catania, Sicily, endorsed by the ESCAP Research Academy.
Riccioni A., Siracusano M., Davico C., Klauser P., Morcillo C., Ougrin D., Vitiello B., Armando M., Cortese S., Mazzone L. et al., 2023/04. European child & adolescent psychiatry, 32 (4) pp. 725-727. Peer-reviewed.
 
Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adults.
Solmi M., Thompson T., Estradé A., Agorastos A., Radua J., Cortese S., Dragioti E., Leisch F., Vancampfort D., Thygesen L.C. et al., 2023/04/01. Journal of affective disorders, 326 pp. 249-261. Peer-reviewed.
Tau Transfer via Extracellular Vesicles Disturbs the Astrocytic Mitochondrial System.
Perbet R., Zufferey V., Leroux E., Parietti E., Espourteille J., Culebras L., Perriot S., Du Pasquier R., Bégard S., Deramecourt V. et al., 2023/03/23. Cells, 12 (7) p. 985. Peer-reviewed.
 
Bridging the gaps towards precision psychiatry: Mechanistic biomarkers for early detection and intervention.
Do K.Q., 2023/03. Psychiatry research, 321 p. 115064. Peer-reviewed.
Low protein-induced intrauterine growth restriction as a risk factor for schizophrenia phenotype in a rat model: assessing the role of oxidative stress and neuroinflammation interaction.
Allgäuer L., Cabungcal J.H., Yzydorczyk C., Do K.Q., Dwir D., 2023/02/01. Translational psychiatry, 13 (1) p. 30. Peer-reviewed.
Perceived impact of the COVID-19 pandemic on child and adolescent psychiatric services after 1 year (February/March 2021): ESCAP CovCAP survey.
Revet A., Hebebrand J., Anagnostopoulos D., Kehoe L.A., Gradl-Dietsch G., COVID-19 Child and Adolescent Psychiatry Consortium, Klauser P., 2023/02. European child & adolescent psychiatry, 32 (2) pp. 249-256. Peer-reviewed.
The 2022 ESCAP Research Academy Workshop: New Perspectives on Eating Disorders.
Revet A., Hebebrand J., Klauser P., 2023/02. European child & adolescent psychiatry, 32 (2) pp. 369-370. Peer-reviewed.
Psychiatrie : ce qui a changé en 2022 [Psychiatry: what's new in 2022]
Berney S., Mettraux M., Franz T., Candaux F., Eggimann A., Fehr N., Abrahamyan Empson L., Conus P., Baumann P.S., 2023/01/18. Revue medicale suisse, 19 (N° 809-10) pp. 82-85. Peer-reviewed.
Evolutions of Metabolic Parameters Following Switches of Psychotropic Drugs: A Longitudinal Cohort Study.
Piras M., Ranjbar S., Laaboub N., Grosu C., Gamma F., Plessen K.J., von Gunten A., Conus P., Eap C.B., 2023/01/03. Schizophrenia bulletin, 49 (1) pp. 24-33. Peer-reviewed.
 
Multimodal Magnetic Resonance Imaging Depicts Widespread and Subregion Specific Anomalies in the Thalamus of Early-Psychosis and Chronic Schizophrenia Patients.
Alemán-Gómez Y., Baumgartner T., Klauser P., Cleusix M., Jenni R., Hagmann P., Conus P., Do K.Q., Bach Cuadra M., Baumann P.S. et al., 2023/01/03. Schizophrenia bulletin, 49 (1) pp. 196-207. Peer-reviewed.
 
ABLE: Automated Brain Lines Extraction Based on Laplacian Surface Collapse.
Fernández-Pena A., Martín de Blas D., Navas-Sánchez F.J., Marcos-Vidal L., M Gordaliza P., Santonja J., Janssen J., Carmona S., Desco M., Alemán-Gómez Y., 2023/01. Neuroinformatics, 21 (1) pp. 145-162. Peer-reviewed.
Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION project.
Monfort A., Cardoso E., Eap C.B., Fischer Fumeaux C.J., Graz M.B., Morisod Harari M., Weisskopf E., Gandia P., Allegaert K., Nordeng H. et al., 2023. Frontiers in psychiatry, 14 p. 1167870. Peer-reviewed.
Towards Automated Brain Aneurysm Detection in TOF-MRA: Open Data, Weak Labels, and Anatomical Knowledge.
Di Noto T., Marie G., Tourbier S., Alemán-Gómez Y., Esteban O., Saliou G., Cuadra M.B., Hagmann P., Richiardi J., 2023/01. Neuroinformatics, 21 (1) pp. 21-34. Peer-reviewed.
Psychotic features, particularly mood incongruence, as a hallmark of severity of bipolar I disorder.
Elowe J., Vallat J., Castelao E., Strippoli M.F., Gholam M., Ranjbar S., Glaus J., Merikangas K., Lavigne B., Marquet P. et al., 2022/12/18. International journal of bipolar disorders, 10 (1) p. 31. Peer-reviewed.
Sleep spindles in people with schizophrenia, schizoaffective disorders or bipolar disorders: a pilot study in a general population-based cohort.
Petit J.M., Strippoli M.F., Stephan A., Ranjbar S., Haba-Rubio J., Solelhac G., Heinzer R., Preisig M., Siclari F., Do K.Q., 2022/12/03. BMC psychiatry, 22 (1) p. 758. Peer-reviewed.
Clinical predictors of antipsychotic treatment resistance: Development and internal validation of a prognostic prediction model by the STRATA-G consortium.
Smart S.E., Agbedjro D., Pardiñas A.F., Ajnakina O., Alameda L., Andreassen O.A., Barnes TRE, Berardi D., Camporesi S., Cleusix M. et al., 2022/12. Schizophrenia research, 250 pp. 1-9. Peer-reviewed.
Gene set enrichment analysis of pathophysiological pathways highlights oxidative stress in psychosis.
Pistis G., Vázquez-Bourgon J., Fournier M., Jenni R., Cleusix M., Papiol S., Smart S.E., Pardiñas A.F., Walters JTR, MacCabe J.H. et al., 2022/12. Molecular psychiatry, 27 (12) pp. 5135-5143. Peer-reviewed.
 
Towards a machine-learning assisted diagnosis of psychiatric disorders and their operationalization in preclinical research: Evidence from studies on addiction-like behaviour in individual rats.
Jadhav K.S., Boury Jamot B., Deroche-Gamonet V., Belin D., Boutrel B., 2022/12. The European journal of neuroscience, 56 (11) pp. 6069-6083. Peer-reviewed.
Alterations in TRN-anterodorsal thalamocortical circuits affect sleep architecture and homeostatic processes in oxidative stress vulnerable Gclm<sup>-/-</sup> mice.
Czekus C., Steullet P., Orero López A., Bozic I., Rusterholz T., Bandarabadi M., Do K.Q., Gutierrez Herrera C., 2022/11. Molecular psychiatry, 27 (11) pp. 4394-4406. Peer-reviewed.
Deletion of Crtc1 leads to hippocampal neuroenergetic impairments associated with depressive-like behavior.
Cherix A., Poitry-Yamate C., Lanz B., Zanoletti O., Grosse J., Sandi C., Gruetter R., Cardinaux J.R., 2022/11. Molecular psychiatry, 27 (11) pp. 4485-4501. Peer-reviewed.
The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samples.
Perry B.I., Vandenberghe F., Garrido-Torres N., Osimo E.F., Piras M., Vazquez-Bourgon J., Upthegrove R., Grosu C., De La Foz V.O., Jones P.B. et al., 2022/11. The Lancet regional health. Europe, 22 p. 100493. Peer-reviewed.
Common Genetic Variation and Age of Onset of Anorexia Nervosa.
Watson H.J., Thornton L.M., Yilmaz Z., Baker J.H., Coleman JRI, Adan RAH, Alfredsson L., Andreassen O.A., Ask H., Berrettini W.H. et al., 2022/10. Biological psychiatry global open science, 2 (4) pp. 368-378. Peer-reviewed.
 
Correction to: ESCAP CovCAP survey of heads of academic departments to assess the perceived initial (April/May 2020) impact of the COVID-19 pandemic on child and adolescent psychiatry services.
Revet A., Hebebrand J., Anagnostopoulos D., Kehoe L.A., Klauser P., 2022/10..
Time of exposure to social defeat stress during childhood and adolescence and redox dysregulation on long-lasting behavioral changes, a translational study.
Schnider M., Jenni R., Ramain J., Camporesi S., Golay P., Alameda L., Conus P., Do K.Q., Steullet P., 2022/09/26. Translational psychiatry, 12 (1) p. 413. Peer-reviewed.
Correction: Hippocampal circuit dysfunction in psychosis.
Knight S., McCutcheon R., Dwir D., Grace A.A., O'Daly O., McGuire P., Modinos G., 2022/09/12. Translational psychiatry, 12 (1) p. 382. Peer-reviewed.
Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia; Response to "Adaptive changes to oxidative stress in schizophrenia by Lena Palaniyappan".
Cuenod M., Steullet P., Cabungcal J.H., Dwir D., Khadimallah I., Klauser P., Conus P., Do K.Q., 2022/09. Molecular psychiatry, 27 (9) pp. 3567-3568. Peer-reviewed.
Hippocampal circuit dysfunction in psychosis.
Knight S., McCutcheon R., Dwir D., Grace A.A., O'Daly O., McGuire P., Modinos G., 2022/08/25. Translational psychiatry, 12 (1) p. 344. Peer-reviewed.
A multi-scale probabilistic atlas of the human connectome.
Alemán-Gómez Y., Griffa A., Houde J.C., Najdenovska E., Magon S., Cuadra M.B., Descoteaux M., Hagmann P., 2022/08/23. Scientific data, 9 (1) p. 516. Peer-reviewed.
CYP2C19 expression modulates affective functioning and hippocampal subiculum volume-a large single-center community-dwelling cohort study.
Grosu C., Trofimova O., Gholam-Rezaee M., Strippoli M.F., Kherif F., Lutti A., Preisig M., Draganski B., Eap C.B., 2022/08/05. Translational psychiatry, 12 (1) p. 316. Peer-reviewed.
Can epigenetics shine a light on the biological pathways underlying major mental disorders?
Alameda L., Trotta G., Quigley H., Rodriguez V., Gadelrab R., Dwir D., Dempster E., Wong CCY, Forti M.D., 2022/07. Psychological medicine, 52 (9) pp. 1645-1665. Peer-reviewed.
The interplay of hypoxic and mental stress: Implications for anxiety and depressive disorders.
Burtscher J., Niedermeier M., Hüfner K., van den Burg E., Kopp M., Stoop R., Burtscher M., Gatterer H., Millet G.P., 2022/07. Neuroscience and biobehavioral reviews, 138 p. 104718. Peer-reviewed.
 
Effects of psychotropic switches on weight change: a prospective cohort study
Piras M., Ranjbar S., Dubath C., Laaboub N., Grosu C., Gamma F., Von Plessen K., Von Gunten A., Conus P., Eap C., 2022/06. pp. S731-S731 dans European Psychiatry.
 
Reversing anterior insular cortex neuronal hypoexcitability attenuates compulsive behavior in adolescent rats.
Jadhav K.S., Bernheim A.P., Aeschlimann L., Kirschmann G., Decosterd I., Hoffman A.F., Lupica C.R., Boutrel B., 2022/05/24. Proceedings of the National Academy of Sciences of the United States of America, 119 (21) pp. e2121247119. Peer-reviewed.
Depthgram: Visualizing outliers in high-dimensional functional data with application to fMRI data exploration.
Alemán-Gómez Y., Arribas-Gil A., Desco M., Elías A., Romo J., 2022/05/20. Statistics in medicine, 41 (11) pp. 2005-2024. Peer-reviewed.
Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort.
Laaboub N., Dubath C., Ranjbar S., Sibailly G., Grosu C., Piras M., Délessert D., Richard-Lepouriel H., Ansermot N., Crettol S. et al., 2022/05/17. BMC psychiatry, 22 (1) p. 342. Peer-reviewed.
Daily Dose Effects of Risperidone on Weight and Other Metabolic Parameters: A Prospective Cohort Study.
Piras M., Dubath C., Gholam M., Laaboub N., Grosu C., Gamma F., Solida A., Plessen K.J., von Gunten A., Conus P. et al., 2022/05/09. The Journal of clinical psychiatry, 83 (4) pp. 21m14110. Peer-reviewed.
ESCAP CovCAP survey of heads of academic departments to assess the perceived initial (April/May 2020) impact of the COVID-19 pandemic on child and adolescent psychiatry services.
Revet A., Hebebrand J., Anagnostopoulos D., Kehoe L.A., COVID-19 Child and Adolescent Psychiatry Consortium, Klauser P., 2022/05. European child & adolescent psychiatry, 31 (5) pp. 795-804. Peer-reviewed.
 
Pleotropic Effects of 15q13.3 Microdeletion on Interneuron Development: Insight on Spatiotemporal Molecular Events Leading to Neurodevelopmental Disorders.
Steullet P., 2022/04/15. Biological psychiatry, 91 (8) pp. 694-696. Peer-reviewed.
Environmental factors in offspring of parents with mood disorders and their role in parent-child transmission: findings from a 14-year prospective high-risk study.
Moulin F., Gholam M., Strippoli M.F., Castelao E., Merikangas K.R., Stapp E.K., Marquet P., Aubry J.M., Plessen K.J., Di Giacomo F. et al., 2022/04/06. International journal of bipolar disorders, 10 (1) p. 11. Peer-reviewed.
Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia.
Cuenod M., Steullet P., Cabungcal J.H., Dwir D., Khadimallah I., Klauser P., Conus P., Do K.Q., 2022/04. Molecular psychiatry, 27 (4) pp. 1886-1897. Peer-reviewed.
 
Choosing between cocaine and sucrose under the influence: testing the effect of cocaine tolerance.
Vandaele Y., Ahmed S.H., 2022/04. Psychopharmacology, 239 (4) pp. 1053-1063. Peer-reviewed.
 
Clinical high risk for psychosis paradigm for CAP: do not throw the baby out with the bathwater.
Klauser P., Revet A., Anagnostopoulos D., Hebebrand J., Moreno C., Raynaud J.P., Armando M., 2022/04. European child & adolescent psychiatry, 31 (4) pp. 685-687. Peer-reviewed.
Developmental oxidative stress leads to T-type Ca<sup>2+</sup> channel hypofunction in thalamic reticular nucleus of mouse models pertinent to schizophrenia.
El Khoueiry C., Cabungcal J.H., Rovó Z., Fournier M., Do K.Q., Steullet P., 2022/04. Molecular psychiatry, 27 (4) pp. 2042-2051. Peer-reviewed.
Olanzapine-associated dose-dependent alterations for weight and metabolic parameters in a prospective cohort.
Schoretsanitis G., Dubath C., Grosu C., Piras M., Laaboub N., Ranjbar S., Ansermot N., Crettol S., Vandenberghe F., Gamma F. et al., 2022/04. Basic & clinical pharmacology & toxicology, 130 (4) pp. 531-541. Peer-reviewed.
Le liraglutide a-t-il sa place en psychiatrie ? [Does liraglutide have a place in psychiatry ?]
Frantz J., Favre L., Vandenberghe F., 2022/03/23. Revue medicale suisse, 18 (774) pp. 522-526. Peer-reviewed.
Viral vectors for opto-electrode recording and photometry-based imaging of oxytocin neurons in anesthetized and socially interacting rats.
Tang Y., Benusiglio D., Lefevre A., Küppers S., Lapies O., Kerspern D., Charlet A., Grinevich V., 2022/03/18. STAR protocols, 3 (1) p. 101032. Peer-reviewed.
 
The petting factor: Oxytocin and social touch.
Tang Y., Stoop R., 2022/03/16. Neuron, 110 (6) pp. 909-911. Peer-reviewed.
 
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels.
de Leon J., Schoretsanitis G., Smith R.L., Molden E., Solismaa A., Seppälä N., Kopeček M., Švancer P., Olmos I., Ricciardi C. et al., 2022/03. Pharmacopsychiatry, 55 (2) pp. 73-86. Peer-reviewed.
 
Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels.
de Leon J., Schoretsanitis G., Smith R.L., Molden E., Solismaa A., Seppälä N., Kopeček M., Švancer P., Olmos I., Ricciardi C. et al., 2022/03..
 
Dosimetry of Microelectrodes Array Chips for Electrophysiological Studies Under Simultaneous Radio Frequency Exposures
Nefzi Amani, Orlacchio Rosa, Carr Lynn, Lemercier Clement E., Khoueiry Corinne El, Lewis Noelle, Leveque Philippe, Arnaud-Cormos Delia, 2022/03. IEEE Transactions on Microwave Theory and Techniques, 70 (3) pp. 1871-1881.
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia.
Pardiñas A.F., Smart S.E., Willcocks I.R., Holmans P.A., Dennison C.A., Lynham A.J., Legge S.E., Baune B.T., Bigdeli T.B., Cairns M.J. et al., 2022/03/01. JAMA psychiatry, 79 (3) pp. 260-269. Peer-reviewed.
Psychotropic Drug Prescription in Children and Adolescents: Approved Medications in European Countries and the United States.
Smogur M., Onesanu A., Plessen K.J., Eap C.B., Ansermot N., 2022/03. Journal of child and adolescent psychopharmacology, 32 (2) pp. 80-88. Peer-reviewed.
Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times - Children and Adolescents (COH-FIT-C&A).
Solmi M., Estradé A., Thompson T., Agorastos A., Radua J., Cortese S., Dragioti E., Leisch F., Vancampfort D., Thygesen L.C. et al., 2022/02/15. Journal of affective disorders, 299 pp. 367-376. Peer-reviewed.
The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting physical and mental health effects of the COVID-19 pandemic.
Solmi M., Estradé A., Thompson T., Agorastos A., Radua J., Cortese S., Dragioti E., Leisch F., Vancampfort D., Thygesen L.C. et al., 2022/02/15. Journal of affective disorders, 299 pp. 393-407. Peer-reviewed.
Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies.
Leroux E., Perbet R., Caillierez R., Richetin K., Lieger S., Espourteille J., Bouillet T., Bégard S., Danis C., Loyens A. et al., 2022/02/02. Molecular Therapy, 30 (2) pp. 782-797. Peer-reviewed.
Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors.
Mullins N., Kang J., Campos A.I., Coleman JRI, Edwards A.C., Galfalvy H., Levey D.F., Lori A., Shabalin A., Starnawska A. et al., 2022/02/01. Biological psychiatry, 91 (3) pp. 313-327. Peer-reviewed.
Mitochondrial, exosomal miR137-COX6A2 and gamma synchrony as biomarkers of parvalbumin interneurons, psychopathology, and neurocognition in schizophrenia.
Khadimallah I., Jenni R., Cabungcal J.H., Cleusix M., Fournier M., Beard E., Klauser P., Knebel J.F., Murray M.M., Retsa C. et al., 2022/02. Molecular psychiatry, 27 (2) pp. 1192-1204. Peer-reviewed.
Engineered fluidic device to achieve multiplexed monitoring of cell cultures with digital holographic microscopy.
Bélanger E., Benadiba C., Rioux-Pellerin É., Becq F., Jourdain P., Marquet P., 2022/01/03. Optics express, 30 (1) pp. 414-426. Peer-reviewed.
Body Composition Assessment by Dual-Energy X-Ray Absorptiometry: A Useful Tool for the Diagnosis of Lipedema.
Buso G., Favre L., Vionnet N., Gonzalez-Rodriguez E., Hans D., Puder J.J., Dubath C., Eap C.B., Raffoul W., Collet T.H. et al., 2022. Obesity facts, 15 (6) pp. 762-773. Peer-reviewed.
Bridging structural MRI with cognitive function for individual level classification of early psychosis via deep learning.
Wen Y., Zhou C., Chen L., Deng Y., Cleusix M., Jenni R., Conus P., Do K.Q., Xin L., 2022. Frontiers in psychiatry, 13 p. 1075564. Peer-reviewed.
Case Report: Opioid Use Disorder Associated With Low/Moderate Dose of Loperamide in an Intellectual Disability Patient With CYP3A and P-Glycoprotein Reduced Activity.
Guinchat V., Ansermot N., Ing Lorenzini K., Politis D., Daali Y., Eap C.B., Crettol S., 2022. Frontiers in psychiatry, 13 p. 910684. Peer-reviewed.
New Insights Into the Pivotal Role of CREB-Regulated Transcription Coactivator 1 in Depression and Comorbid Obesity.
Rossetti C., Cherix A., Guiraud L.F., Cardinaux J.R., 2022. Frontiers in molecular neuroscience, 15 p. 810641. Peer-reviewed.
 
Pharmacotherapy of Personality Disorders
Baumann Pierre, Herpertz Sabine C., 2022. dans NeuroPsychopharmacotherapy, Riederer, P. Laux, G. Nagatsu T. Le W. Riederer C..
 
Tests pharmacogénétiques et surveillance thérapeutique des médicaments: pertinence clinique dans les troubles bipolaires
Kuzin Maxim, Baumann Pierre, 2022. Leading Opinions Neurologie & Psychiatrie 1 pp. 6-11.
 
The influence of childhood trauma on the treatment outcomes of pharmacological and/or psychological interventions for adolescents and adults with bipolar disorder: A systematic review and meta-analysis.
Wrobel A.L., Jayasinghe A., Russell S.E., Marx W., Alameda L., Dean O.M., Cotton S.M., Berk M., Turner A., 2022/01/01. Journal of affective disorders, 296 pp. 350-362. Peer-reviewed.
 
Whole-brain high-resolution metabolite mapping with 3D compressed-sensing SENSE low-rank <sup>1</sup> H FID-MRSI.
Klauser A., Klauser P., Grouiller F., Courvoisier S., Lazeyras F., 2022/01. NMR in biomedicine, 35 (1) pp. e4615. Peer-reviewed.
 
Arzneimittelsicherheit bei bipolaren Störungen: Therapeutisches Drug Monitoring und pharmakogenetische Aspekte
Baumann Pierre, Kuzin Maxim, 2021/12/21. brainMAG.
Gabapentinoïdes : mésusages et addictions [Gabapentinoids : misuses and addictions]
Grandjean C., Crettol Wavre S., Khazaal Y., Sanchis Zozaya J., Ansermot N., Vandenberghe F., Sibailly G., Eap C.B., 2021/12/15. Revue medicale suisse, 17 (763) pp. 2206-2208. Peer-reviewed.
 
Investigating the Relations Between Caffeine-Derived Metabolites and Plasma Lipids in 2 Population-Based Studies.
Petrovic D., Pruijm M., Ponte B., Dhayat N.A., Ackermann D., Ehret G., Ansermot N., Vogt B., Martin P.Y., Stringhini S. et al., 2021/12. Mayo Clinic proceedings, 96 (12) pp. 3071-3085. Peer-reviewed.
Potential effects of Covid-19 on training in CAP: the balance after a year.
Deschamps P., Bailey S., Dubicka B., Hansen A.S., Hebebrand J., Jacobs B., Kapornai K., Klauser P., Kumperscak H.G., Revet A. et al., 2021/12. European child & adolescent psychiatry, 30 (12) pp. 1833-1837. Peer-reviewed.
Six months functional response to early psychosis intervention program best predicts outcome after three years.
Golay P., Ramain J., Jenni R., Klauser P., Mebdouhi N., Conus P., Solida A., 2021/12. Schizophrenia research, 238 pp. 62-69. Peer-reviewed.
 
Roadmap on Digital Holography-Based Quantitative Phase Imaging.
Balasubramani V., Kujawińska M., Allier C., Anand V., Cheng C.J., Depeursinge C., Hai N., Juodkazis S., Kalkman J., Kuś A. et al., 2021/11/26. Journal of imaging, 7 (12). Peer-reviewed.
 
Traitement des troubles bipolaires. Pharmacovigilance. Monitoring thérapeutique des médicaments et aspects pharmacogénétiques
Baumann Pierre, Kuzin Maxim, 2021/11/21. médMAG, 1 (2) pp. 46-51.
 
Live-imaging of Mitochondrial System in Cultured Astrocytes.
Espourteille J., Zufferey V., Laurent J.H., Richetin K., 2021/11/16. Journal of visualized experiments p. 177. Peer-reviewed.
Effect of Quetiapine, from Low to High Dose, on Weight and Metabolic Traits: Results from a Prospective Cohort Study.
Dubath C., Piras M., Gholam M., Laaboub N., Grosu C., Sentissi O., Gamma F., Solida A., von Gunten A., Conus P. et al., 2021/11. Pharmacopsychiatry, 54 (6) pp. 279-286. Peer-reviewed.
Metabolomic alteration induced by psychotropic drugs: Short-term metabolite profile as a predictor of weight gain evolution.
Lenski M., Sidibé J., Gholam M., Hennart B., Dubath C., Augsburger M., von Gunten A., Conus P., Allorge D., Thomas A. et al., 2021/11. Clinical and translational science, 14 (6) pp. 2544-2555. Peer-reviewed.
Role of adult hippocampal neurogenesis in the antidepressant actions of lactate.
Carrard A., Cassé F., Carron C., Burlet-Godinot S., Toni N., Magistretti P.J., Martin J.L., 2021/11. Molecular psychiatry, 26 (11) pp. 6723-6735. Peer-reviewed.
Fronto-Temporal Disconnection Within the Presence Hallucination Network in Psychotic Patients With Passivity Experiences.
Stripeikyte G., Potheegadoo J., Progin P., Rognini G., Blondiaux E., Salomon R., Griffa A., Hagmann P., Faivre N., Do K.Q. et al., 2021/10/21. Schizophrenia bulletin, 47 (6) pp. 1718-1728. Peer-reviewed.
Timely N-Acetyl-Cysteine and Environmental Enrichment Rescue Oxidative Stress-Induced Parvalbumin Interneuron Impairments via MMP9/RAGE Pathway: A Translational Approach for Early Intervention in Psychosis.
Dwir D., Cabungcal J.H., Xin L., Giangreco B., Parietti E., Cleusix M., Jenni R., Klauser P., Conus P., Cuénod M. et al., 2021/10/21. Schizophrenia bulletin, 47 (6) pp. 1782-1794. Peer-reviewed.
Gerd Laux, Walter E. Müller (Herausgeber): Psychopharmakologie und Psychopharmakotherapie kompakt. Weiterbildungs-Curriculum zum Facharzt für Psychiatrie und Psychotherapie
Baumann Pierre, 2021/10/20. Swiss Archives of Neurology, Psychiatry and Psychotherapy, 172.
Recommandations de prise en charge des mésusages et addictions aux benzodiazepines [Recommendations for management of misuses and addictions to benzodiazepines]
Grandjean C., Crettol Wavre S., Khazaal Y., Sanchis Zozaya J., Ansermot N., Vandenberghe F., Sibailly G., Eap C.B., 2021/10/13. Revue medicale suisse, 17 (754) pp. 1754-1759. Peer-reviewed.
French validation of the M-Back questionnaire: assessing clinicians' knowledge about metabolic syndrome in psychiatry
Golay P., Calderoni M., Eap C. B., Conus P., 2021/10/10. Swiss Archives of Neurology, Psychiatry and Psychotherapy, 105 (w10011). Peer-reviewed.
Correction: Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort.
Dubath C., Gholam-Rezaee M., Sjaarda J., Levier A., Saigi-Morgui N., Delacrétaz A., Glatard A., Panczak R., Correll C.U., Solida A. et al., 2021/10/07..
 
Brain glycogen metabolism: A possible link between sleep disturbances, headache and depression.
Petit J.M., Eren-Koçak E., Karatas H., Magistretti P., Dalkara T., 2021/10. Sleep medicine reviews, 59 p. 101449. Peer-reviewed.
 
Prescription of St John's Wort extracts: clinical risks due to differences in their hyperforin content
BAUMANN Pierre, 2021/10. Minerva Psychiatry, 62 (3) pp. 198-9.
 
Structural brain correlates in major depression, anxiety disorders and post-traumatic stress disorder: A voxel-based morphometry meta-analysis.
Serra-Blasco M., Radua J., Soriano-Mas C., Gómez-Benlloch A., Porta-Casteràs D., Carulla-Roig M., Albajes-Eizagirre A., Arnone D., Klauser P., Canales-Rodríguez E.J. et al., 2021/10. Neuroscience and biobehavioral reviews, 129 pp. 269-281. Peer-reviewed.
Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants.
Eap C.B., Gründer G., Baumann P., Ansermot N., Conca A., Corruble E., Crettol S., Dahl M.L., de Leon J., Greiner C. et al., 2021/10. The world journal of biological psychiatry, 22 (8) pp. 561-628. Peer-reviewed.
Inflammation, Anxiety, and Stress in Attention-Deficit/Hyperactivity Disorder.
Saccaro L.F., Schilliger Z., Perroud N., Piguet C., 2021/09/24. Biomedicines, 9 (10) p. 1313. Peer-reviewed.
Topology predicts long-term functional outcome in early psychosis.
Fournier M., Scolamiero M., Gholam-Rezaee M.M., Cleusix M., Jenni R., Ferrari C., Golay P., Baumann P.S., Cuenod M., Conus P. et al., 2021/09. Molecular psychiatry, 26 (9) pp. 5335-5346. Peer-reviewed.
 
Clinical Pharmacy in Psychiatry: Towards Promoting Clinical Expertise in Psychopharmacology.
Javelot H., Gitahy Falcao Faria C., Vandenberghe F., Dizet S., Langrée B., Le Maout M., Straczek C., Egron A., Erb A., Sujol G. et al., 2021/08/21. Pharmacy, 9 (3) p. 146. Peer-reviewed.
A Simple Spatial-independent Associative and Reversal Learning Task in Mice.
Magara F., Boury-Jamot B., Hörnberg H., 2021/08/05. Bio-protocol, 11 (15) pp. e4108. Peer-reviewed.
Inflammation, anxiety, and stress in bipolar disorder and borderline personality disorder: A narrative review.
Saccaro L.F., Schilliger Z., Dayer A., Perroud N., Piguet C., 2021/08. Neuroscience and biobehavioral reviews, 127 pp. 184-192. Peer-reviewed.
 
The palaeoenvironmental context of Toarcian vertebrate-yielding shales of southern France (Hérault)
Bomou B., Suan G., Schlögl J., Grosjean A.-S., Suchéras-Marx B., Adatte T., Spangenberg J. E., Fouché S., Zacai A., Gibert C. et al., 2021/07/19. pp. SP514-2021-16 dans Carbon Cycle and Ecosystem Response to the Jenkyns Event in the Early Toarcian (Jurassic), Geological Society, London, Special Publications.
 
A multimodal approach to studying the relationship between peripheral glutathione, brain glutamate, and cognition in health and in schizophrenia.
Coughlin J.M., Yang K., Marsman A., Pradhan S., Wang M., Ward R.E., Bonekamp S., Ambinder E.B., Higgs C.P., Kim P.K. et al., 2021/07. Molecular psychiatry, 26 (7) pp. 3502-3511. Peer-reviewed.
 
Individual deviations from normative models of brain structure in a large cross-sectional schizophrenia cohort.
Lv J., Di Biase M., Cash RFH, Cocchi L., Cropley V.L., Klauser P., Tian Y., Bayer J., Schmaal L., Cetin-Karayumak S. et al., 2021/07. Molecular psychiatry, 26 (7) pp. 3512-3523. Peer-reviewed.
 
The role of cytochrome P450 enzyme genetic variants in cannabis hyperemesis syndrome-A case report.
Kuzin M., Xepapadakos F., Scharrer I., Augsburger M., Eap C.B., Schoretsanitis G., 2021/07. Basic & clinical pharmacology & toxicology, 129 (1) pp. 82-85. Peer-reviewed.
Valproate is associated with early decrease of high-density lipoprotein cholesterol levels in the psychiatric population.
Delacrétaz A., Glatard A., Dubath C., Gholam M., Gamma F., von Gunten A., Conus P., Eap C.B., 2021/07. Basic and clinical pharmacology and toxicology, 129 (1) pp. 26-35. Peer-reviewed.
Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort.
Dubath C., Gholam-Rezaee M., Sjaarda J., Levier A., Saigi-Morgui N., Delacrétaz A., Glatard A., Panczak R., Correll C.U., Solida A. et al., 2021/06/26. Translational psychiatry, 11 (1) p. 360. Peer-reviewed.
Benzodiazépines, addiction et autorisation cantonale : cadre juridique et implications cliniques [Benzodiazepines, addiction and cantonal authorization : legal framework and clinical implications.]
Junod V., Baud C.A., Broers B., Vandenberghe F., Simon O., 2021/06/09. Revue medicale suisse, 17 (742) pp. 1115-1117.
Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data.
Merritt K., McGuire P.K., Egerton A., 1H-MRS in Schizophrenia Investigators, Aleman A., Block W., Bloemen OJN, Borgan F., Bustillo J.R., Capizzano A.A. et al., 2021/06/01. JAMA psychiatry, 78 (6) pp. 667-681. Peer-reviewed.
 
Plasma Concentrations and Cardiovascular Effects of Citalopram Enantiomers After Oral Versus Infusion Citalopram Therapy in Dextromethorphan-Mephenytoin-Phenotyped Patients With Major Depression.
Baumann P., Bertschy G., Ramseier F., Nil R., 2021/06/01. Therapeutic drug monitoring, 43 (3) pp. 436-442. Peer-reviewed.
Traitement de l’insomnie, par quoi commencer ? [Treatment of insomnia, with what to start ?]
Grandjean C., Crettol Wavre S., Ansermot N., Vandenberghe F., Sibailly G., Eap C.B., 2021/05/05. Revue medicale suisse, 17 (737) pp. 890-897. Peer-reviewed.
 
Redox Dysregulation, Myelination Deficit and Dysconnectivity in Schizophrenia: A Translational Study in First Episode Patients and Experimental Models
Do Kim Q., Cabungcal Jan-Harry, Cleusix Martine, Dwir Daniella, Fournier Margot, Griffa Alessandra, Gruetter Rolf, Hagmann Patric, Jenni Raoul, Klauser Paul et al., 2021/05. pp. S56 dans Biological Psychiatry.
 
Probing the decision-making mechanisms underlying choice between drug and nondrug rewards in rats.
Vandaele Y., Lenoir M., Vouillac-Mendoza C., Guillem K., Ahmed S.H., 2021/04/26. eLife, 10 pp. e64993. Peer-reviewed.
 
Astrocytes mediate the effect of oxytocin in the central amygdala on neuronal activity and affective states in rodents.
Wahis J., Baudon A., Althammer F., Kerspern D., Goyon S., Hagiwara D., Lefevre A., Barteczko L., Boury-Jamot B., Bellanger B. et al., 2021/04. Nature Neuroscience, 24 (4) pp. 529-541. Peer-reviewed.
Gradient of electro-convulsive therapy's antidepressant effects along the longitudinal hippocampal axis.
Gyger L., Regen F., Ramponi C., Marquis R., Mall J.F., Swierkosz-Lenart K., von Gunten A., Toni N., Kherif F., Heuser I. et al., 2021/03/29. Translational psychiatry, 11 (1) p. 191. Peer-reviewed.
Bioavailability of Vortioxetine After a Roux-en-Y Gastric Bypass.
Vandenberghe F., Gilet P., Daali Y., Favre L., Eap C.B., 2021/03. Obesity surgery, 31 (3) pp. 1353-1356. Peer-reviewed.
 
Habit, choice, and addiction.
Vandaele Y., Ahmed S.H., 2021/03. Neuropsychopharmacology, 46 (4) pp. 689-698. Peer-reviewed.
 
Reactive astrocyte nomenclature, definitions, and future directions.
Escartin C., Galea E., Lakatos A., O'Callaghan J.P., Petzold G.C., Serrano-Pozo A., Steinhäuser C., Volterra A., Carmignoto G., Agarwal A. et al., 2021/03. Nature neuroscience, 24 (3) pp. 312-325. Peer-reviewed.
Author Correction: A brain-wide functional map of the serotonergic responses to acute stress and fluoxetine.
Grandjean J., Corcoba A., Kahn M.C., Upton A.L., Deneris E.S., Seifritz E., Helmchen F., Mansuy I.M., Mann E.O., Rudin M. et al., 2021/02/15. Nature communications, 12 (1) p. 1168. Peer-reviewed.
 
Contributions of left and right anterior temporal lobes to semantic cognition: Evidence from patients with small temporopolar lesions.
Poch C., Toledano R., García-Morales I., Alemán-Gómez Y., Gil-Nagel A., Campo P., 2021/02/12. Neuropsychologia, 152 p. 107738. Peer-reviewed.
 
Thought consciousness and source monitoring depend on robotically controlled sensorimotor conflicts and illusory states.
Serino A., Pozeg P., Bernasconi F., Solcà M., Hara M., Progin P., Stripeikyte G., Dhanis H., Salomon R., Bleuler H. et al., 2021/01/22. iScience, 24 (1) p. 101955. Peer-reviewed.
Psychiatrie [Psychiatry]
Khazaal Y., Elowe J., Kloucek P., Preisig M., Tadri M., Vandeleur C., Vandenberghe F., Verloo H., Ros T., Von Gunten A., 2021/01/13. Revue medicale suisse, 17 (720-1) pp. 85-89.
 
Agonistes partiels de la dopamine D2: Pharmacologie et signification clinique
Baumann Pierre, Wagner Martin, 2021. Info Neurologie & Psychiatrie.
Associations Between High Plasma Methylxanthine Levels, Sleep Disorders and Polygenic Risk Scores of Caffeine Consumption or Sleep Duration in a Swiss Psychiatric Cohort.
Laaboub N., Gholam M., Sibailly G., Sjaarda J., Delacrétaz A., Dubath C., Grosu C., Piras M., Ansermot N., Crettol S. et al., 2021. Frontiers in psychiatry, 12 p. 756403. Peer-reviewed.
 
Ch. 32. Neurobiologie et schizophrénie
Baumann Philipp Sebastian, Steullet Pascal, 2021/01/01. dans Conus Philipp, Söderström Dag (eds.) Approche psychothérapeutique des psychoses, RMS Editions.
 
Design of Digital Mediation Tool for Self-disclosing PTSD
Gaci Maria, Bendahan Caroline, Cardia Isabelle Vonèche, Fiori Marina, Preissmann Delphine, Gillet Denis, 2021. pp. 259-265 dans Human Interaction, Emerging Technologies and Future Applications III, Springer International Publishing.
 
Die Rezeptvalidierung bei psychiatrischen Patienten. Plädoyer für eine gestärkte Kommunikation zwischen Psychiatrie und Offizin
Stämpfli Dominik, Baumann Pierre, 2021. pharmaJournal 2 pp. 18-20.
Hydroxycarboxylic Acid Receptor 1 and Neuroprotection in a Mouse Model of Cerebral Ischemia-Reperfusion.
Buscemi L., Blochet C., Magistretti P.J., Hirt L., 2021. Frontiers in physiology, 12 p. 689239. Peer-reviewed.
 
La validation d'ordonnance chez le patient psychiatrique. Plaidoyer pour une meilleure communication entre psychiatres et pharmaciens
Stämpfli Dominik, Baumann Pierre, 2021. pharmaJournal 2 pp. 18-20.
 
Les substances psychotropes en Suisse
Baumann Pierre, Eich Philipp, Hasler Gregor, Nick Beat, 2021., Janssen Neuroscience.
 
Partielle D2-Dopamin-Agonisten: Pharmakologie und klinische Bedeutung
Baumann Pierre, Wagner Martin, 2021. Info Neurologie & Psychiatrie, 19 (6) pp. 12-23.
 
Pharmakogenetische Tests und therapeutisches Drug Monitoring: klinische Relevanz bei bipolaren Störungen
Kuzin Maxim, Baumann Pierre, 2021. Leading Opinions Neurologie & Psychiatrie 6 pp. 6-11.
Psychiatrie [Psychiatry]
Khazaal Yasser, Elowe Julien, Kloucek Petr, Preisig Martin, Tadri Myriam, Vandeleur Caroline, Vandenberghe Frederik, Verloo Henk, Ros Tomas, Von Guntenb Armin, 2021. Revue Médicale Suisse, 17 (720-21) pp. 85-89. Peer-reviewed.
 
Psychopharmaka in der Schweiz
Baumann Pierre, Eich Philipp, Hasler Gregor, Nick Beat, 2021., Janssen Neuroscience.
 
Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies.
Munn-Chernoff M.A., Johnson E.C., Chou Y.L., Coleman JRI, Thornton L.M., Walters R.K., Yilmaz Z., Baker J.H., Hübel C., Gordon S. et al., 2021/01. Addiction biology, 26 (1) pp. e12880. Peer-reviewed.
White Matter Alterations Between Brain Network Hubs Underlie Processing Speed Impairment in Patients With Schizophrenia
Klauser Paul, Cropley Vanessa L, Baumann Philipp S, Lv Jinglei, Steullet Pascal, Dwir Daniella, Alemán-Gómez Yasser, Bach Cuadra Meritxell, Cuenod Michel, Do Kim Q et al., 2021/01/01. Schizophrenia Bulletin Open, 2 (1). Peer-reviewed.
 
Θεραπευτική παρακολούθηση φαρμάκων στην Ψυχιατρική και στη Νευρολογία Κατευθυντήριες Οδηγίες στη Νευροψυχοφαρμακολογία, επικαιροποίηση 2017
Schoretsanitis Georg, Pallis E.G., Paulzen Michael, Unterecker Stefan, Schwarz Markus, Conca Andreas, Zernig Gerald, Gründer Gerd, Haen Eckardt, Baumann Pierre et al., 2021. Archives of hellenic medicine, 38 (6) pp. 817-832.
Monitoring caffeine intake in children with a questionnaire and urine collection: a cross-sectional study in a convenience sample in Switzerland.
Rios-Leyvraz M., Bochud M., Tabin R., Genin B., Russo M., Rossier M.F., Eap C.B., Bovet P., Chiolero A., 2020/12. European journal of nutrition, 59 (8) pp. 3537-3543. Peer-reviewed.
Tau accumulation in astrocytes of the dentate gyrus induces neuronal dysfunction and memory deficits in Alzheimer's disease
Richetin Kevin, Steullet Pascal, Pachoud Mathieu, Perbet Romain, Parietti Enea, Maheswaran Mathischan, Eddarkaoui Sabiha, Bégard Séverine, Pythoud Catherine, Rey Maria et al., 2020/12. Nature Neuroscience, 23 (12) pp. 1567-1579. Peer-reviewed.
Thalamus-related anomalies as candidate mechanism-based biomarkers for psychosis.
Steullet P., 2020/12. Schizophrenia research, 226 pp. 147-157. Peer-reviewed.
MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients.
Dwir D., Giangreco B., Xin L., Tenenbaum L., Cabungcal J.H., Steullet P., Goupil A., Cleusix M., Jenni R., Chtarto A. et al., 2020/11. Molecular psychiatry, 25 (11) pp. 2889-2904. Peer-reviewed.
 
Limits to human neurogenesis-really?
Lucassen P.J., Toni N., Kempermann G., Frisen J., Gage F.H., Swaab D.F., 2020/10. Molecular psychiatry, 25 (10) pp. 2207-2209. Peer-reviewed.
Partial‐volume modeling reveals reduced gray matter in specific thalamic nuclei early in the time course of psychosis and chronic schizophrenia
Alemán-Gómez Yasser, Najdenovska Elena, Roine Timo, Fartaria Mário João, Canales-Rodríguez Erick J., Rovó Zita, Hagmann Patric, Conus Philippe, Do Kim Q., Klauser Paul et al., 2020/10. Human Brain Mapping, 41 (14) pp. 4041-4061. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University